16 studies found for:    diabetes and eye and open and active | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
diabetes and eye and open and active | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.
Condition: High Risk Proliferative Diabetic Retinopathy
Interventions: Procedure: Panretinal Photocoagulation (PRP);   Drug: Intravitreous injection of ranibizumab
2 Recruiting An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.
Conditions: Choroidal Neovascularization;   Macular Edema;   Glaucoma, Neovascular;   Diabetic Retinopathy
Intervention: Drug: ranibizumab
3 Unknown  Influence of Acupuncture to Ocular Microcirculation in Patients With Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Procedure: acupuncture
4 Unknown  Doppler Ultrasound Investigation of Microcirculations
Condition: Type 1 Diabetes Mellitus
Interventions: Other: Administration ofOxygen and carbon dioxide;   Other: Administration of Oxygen and carbon dioxide
5 Recruiting A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Condition: Macular Edema After Cataract Surgery in Patients With Diabetes Mellitus
Interventions: Drug: Dexamethasone intravitreal implant;   Drug: Steroid plus NSAID eye drop combination therapy
6 Unknown  Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab
Condition: Complications of Diabetes Mellitus
Intervention: Drug: Intravitreal Avastin injection
7 Unknown  Propranolol for Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Propranolol
8 Not yet recruiting PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs
Conditions: DIABETES;   DIABETIC RETINOPATHY;   DIABETIC NEUROPATHY
Intervention: Drug: CHOLESTYRAMINE
9 Recruiting Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride
Conditions: Type 2 Diabetes;   Hypoglycemia
Interventions: Drug: vildagliptin and metformin (combination);   Drug: glimepiride;   Drug: Metformin
10 Recruiting Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
Condition: Diabetes
Interventions: Drug: Actos (Pioglitazone);   Drug: Acarbose
11 Not yet recruiting Noctura400 Treatment for Diabetic Retinopathy (CANDLE)
Condition: Diabetic Macular Oedema
Interventions: Device: Noctura 400 Eye Mask;   Drug: Ranibizumab
12 Unknown  Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
Condition: Diabetic Retinopathy
Intervention: Drug: bevacizumab
13 Unknown  Efficacy Study of Diabetes Group Visits
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Group Visits
14 Recruiting Prevention of Microvascular Complications in Overweight Diabetics With Surgery or Best Medicine
Condition: Diabetic Kidney Disease
Interventions: Procedure: Optimal medical treatment and surgery;   Procedure: Optimal medical treatment
15 Recruiting Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Condition: Proliferative Diabetic Retinopathy (PDR)
Interventions: Drug: Ranibizumab;   Procedure: Laser photocoagulation;   Procedure: Ranibizumab & laser photocoagulation
16 Not yet recruiting Variable Interval Versus Set Interval Aflibercept for DME
Conditions: Cystoid Macular Edema;   Diabetic Macular Edema
Intervention: Drug: Intravitreal Aflibercept Injection

Indicates status has not been verified in more than two years